100 Epizód

  1. Key Factors for Choosing the Right CDMO

    Közzétéve: 2023. 08. 28.
  2. Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

    Közzétéve: 2023. 08. 21.
  3. Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review

    Közzétéve: 2023. 08. 15.
  4. Drug Patent Reports now available on Amazon

    Közzétéve: 2023. 08. 14.
  5. Artificial Intelligence and Machine Learning in Drug Discovery and Development

    Közzétéve: 2023. 08. 10.
  6. Prevalence and timing of authorized generics in the US market

    Közzétéve: 2023. 08. 08.
  7. Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends

    Közzétéve: 2023. 08. 07.
  8. The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

    Közzétéve: 2023. 08. 05.
  9. Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study

    Közzétéve: 2023. 08. 02.
  10. Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

    Közzétéve: 2023. 07. 28.
  11. DrugPatentWatch reveals NIH funding for patents

    Közzétéve: 2023. 07. 27.
  12. Filing Strategies for Maximizing Pharma Patents

    Közzétéve: 2023. 07. 25.
  13. DrugChatter Featured Questions

    Közzétéve: 2023. 06. 08.
  14. DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights

    Közzétéve: 2023. 05. 22.
  15. NPR and DrugPatentWatch – Can drug injector pens be swapped?

    Közzétéve: 2023. 05. 16.
  16. Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges

    Közzétéve: 2023. 04. 19.
  17. Social Return on Investment

    Közzétéve: 2022. 09. 06.
  18. CDCDB: A large and continuously updated drug combination database

    Közzétéve: 2022. 06. 07.
  19. DrugPatentWatch named “Best of the Web” by Genetic Engineering News

    Közzétéve: 2022. 05. 02.
  20. The value of method of use patent claims in protecting your therapeutic assets

    Közzétéve: 2022. 04. 05.

3 / 5

DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management

Visit the podcast's native language site